Bayer to present new data at Congress of International Society on Thrombosis and Haemostasis

The following is an excerpt of a press release from Bayer. Read the press release in its entirety here. Bayer will present new data highlighting clinical outcomes from its hemophilia A portfolio, which include long-term data from the PROTECT VIII investigational study evaluating use of Jivi® antihemophilic factor (recombinant) PEGylated-aucl. These data will be presented […]